Market Cap 576.06M
Revenue (ttm) 10.01M
Net Income (ttm) -337.71M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -3,373.73%
Debt to Equity Ratio 0.00
Volume 2,790,600
Avg Vol 2,032,416
Day's Range N/A - N/A
Shares Out 171.45M
Stochastic %K 2%
Beta 1.62
Analysts Strong Sell
Price Target $15.20

Company Profile

Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It transforms the drug discovery process with a focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-2608, a pan-mutant and isoform-selective phosphoinostide 3 kinase alpha, or PI3Ka, inhibitor that is in clinical development for the treatment of breast cancer, solid tumor, and vascular malformations; and aGa...

Industry: Biotechnology
Sector: Healthcare
Phone: 617 370 8837
Address:
399 Binney Street, 2nd Floor, Cambridge, United States
fredbull
fredbull Jul. 28 at 2:50 PM
$RLAY $7-10 today. Hidden. So far
0 · Reply
ZacksResearch
ZacksResearch Jul. 25 at 3:34 PM
$RXRX vs. $RLAY: Why RXRX is the Better Bargain in AI-Driven Drug Discovery 🎯 Recursion Pharmaceuticals boasts a diverse pipeline and strategic collaborations, like with NVIDIA, aiming to revolutionize drug discovery with AI. In contrast, Relay Therapeutics relies heavily on its lead candidate, RLY-2608, for two indications, limiting its growth prospects. Discover why RXRX offers better growth potential despite higher valuation, with a strong cash balance supporting its operations into mid-2027 👉 https://www.zacks.com/stock/news/2618085/rxrx-vs-rlay-which-precision-biotech-stock-is-a-better-bet-now?cid=sm-stocktwits-2-2618085-body-3951&ADID=SYND_STOCKTWITS_TWEET_2_2618085_BODY_3951
0 · Reply
TalkMarkets
TalkMarkets Jul. 23 at 9:46 PM
3 Of The 5 Stocks In Our AI-Focused Drug Discovery Portfolio Were Up Significantly Last Week - Here's Why $SDGR $ABCL $RLAY $ABSI $RXRX https://talkmarkets.com/content/stocks--equities/3-of-the-5-stocks-in-our-ai-focused-drug-discovery-portfolio-were-up-significantly-last-week-heres-why?post=511045
0 · Reply
TheDrunkTrader69
TheDrunkTrader69 Jul. 23 at 3:30 PM
0 · Reply
theBigDollarski
theBigDollarski Jul. 23 at 3:27 PM
$RLAY bought my last bunch before liftoff. See you all above 10
0 · Reply
MajorStockTradingLLC
MajorStockTradingLLC Jul. 17 at 2:42 PM
$RLAY Took a micro position in this as "Pauli Two Shoes" my Ai bot said this was a buy.
0 · Reply
Baseball89
Baseball89 Jul. 17 at 2:32 PM
0 · Reply
RunnerSignals
RunnerSignals Jul. 9 at 8:26 PM
$GNS $LXRX $COGT $FUTU $RLAY opened red, closed green with strength. market warriors in action today
0 · Reply
ZacksResearch
ZacksResearch Jul. 7 at 3:23 PM
$RXRX down 22% YTD — Can it turn the tide? After shelving three drug candidates, RXRX focuses on promising REC-4881, showing a 43% reduction in polyp burden in early trials. More data expected in H2 2025, but competitive pressure from $RLAY and $SDGR, who also use AI-driven platforms, looms. Explore RXRX’s potential turnaround here 👉 https://www.zacks.com/commentary/2565928/will-rxrxs-shift-in-pipeline-focus-help-restore-investor-faith?cid=sm-stocktwits-2-2565928-body-850&ADID=SYND_STOCKTWITS_TWEET_2_2565928_BODY_850
0 · Reply
ZacksResearch
ZacksResearch Jul. 2 at 3:53 PM
$RXRX dips 24.1% YTD — facing competitive pressures in the TechBio space Despite its innovative RecursionOS platform and partnerships with Bayer and Roche, RXRX is underperforming the industry, sector, and S&P 500. Competitive pressure from $RLAY and $SDGR adds to the challenge. Discover the full story here 👉 https://www.zacks.com/commentary/2560564/can-rxrxs-ai-based-approach-revolutionize-the-drug-discovery-process?cid=sm-stocktwits-2-2560564-body-656&ADID=SYND_STOCKTWITS_TWEET_2_2560564_BODY_656
0 · Reply
Latest News on RLAY
Relay Therapeutics: What's Next For H2 2025?

Aug 2, 2025, 8:03 AM EDT - 18 hours ago

Relay Therapeutics: What's Next For H2 2025?


Relay Therapeutics: Trying To Find That Right Price

Apr 12, 2025, 9:28 AM EDT - 4 months ago

Relay Therapeutics: Trying To Find That Right Price


Relay Therapeutics: A Precision Oncology Play Worth The Risk

Feb 14, 2025, 2:17 AM EST - 6 months ago

Relay Therapeutics: A Precision Oncology Play Worth The Risk


Crude Oil Gains Over 1%; Relay Therapeutics Shares Spike Higher

Sep 9, 2024, 2:16 PM EDT - 11 months ago

Crude Oil Gains Over 1%; Relay Therapeutics Shares Spike Higher


fredbull
fredbull Jul. 28 at 2:50 PM
$RLAY $7-10 today. Hidden. So far
0 · Reply
ZacksResearch
ZacksResearch Jul. 25 at 3:34 PM
$RXRX vs. $RLAY: Why RXRX is the Better Bargain in AI-Driven Drug Discovery 🎯 Recursion Pharmaceuticals boasts a diverse pipeline and strategic collaborations, like with NVIDIA, aiming to revolutionize drug discovery with AI. In contrast, Relay Therapeutics relies heavily on its lead candidate, RLY-2608, for two indications, limiting its growth prospects. Discover why RXRX offers better growth potential despite higher valuation, with a strong cash balance supporting its operations into mid-2027 👉 https://www.zacks.com/stock/news/2618085/rxrx-vs-rlay-which-precision-biotech-stock-is-a-better-bet-now?cid=sm-stocktwits-2-2618085-body-3951&ADID=SYND_STOCKTWITS_TWEET_2_2618085_BODY_3951
0 · Reply
TalkMarkets
TalkMarkets Jul. 23 at 9:46 PM
3 Of The 5 Stocks In Our AI-Focused Drug Discovery Portfolio Were Up Significantly Last Week - Here's Why $SDGR $ABCL $RLAY $ABSI $RXRX https://talkmarkets.com/content/stocks--equities/3-of-the-5-stocks-in-our-ai-focused-drug-discovery-portfolio-were-up-significantly-last-week-heres-why?post=511045
0 · Reply
TheDrunkTrader69
TheDrunkTrader69 Jul. 23 at 3:30 PM
0 · Reply
theBigDollarski
theBigDollarski Jul. 23 at 3:27 PM
$RLAY bought my last bunch before liftoff. See you all above 10
0 · Reply
MajorStockTradingLLC
MajorStockTradingLLC Jul. 17 at 2:42 PM
$RLAY Took a micro position in this as "Pauli Two Shoes" my Ai bot said this was a buy.
0 · Reply
Baseball89
Baseball89 Jul. 17 at 2:32 PM
0 · Reply
RunnerSignals
RunnerSignals Jul. 9 at 8:26 PM
$GNS $LXRX $COGT $FUTU $RLAY opened red, closed green with strength. market warriors in action today
0 · Reply
ZacksResearch
ZacksResearch Jul. 7 at 3:23 PM
$RXRX down 22% YTD — Can it turn the tide? After shelving three drug candidates, RXRX focuses on promising REC-4881, showing a 43% reduction in polyp burden in early trials. More data expected in H2 2025, but competitive pressure from $RLAY and $SDGR, who also use AI-driven platforms, looms. Explore RXRX’s potential turnaround here 👉 https://www.zacks.com/commentary/2565928/will-rxrxs-shift-in-pipeline-focus-help-restore-investor-faith?cid=sm-stocktwits-2-2565928-body-850&ADID=SYND_STOCKTWITS_TWEET_2_2565928_BODY_850
0 · Reply
ZacksResearch
ZacksResearch Jul. 2 at 3:53 PM
$RXRX dips 24.1% YTD — facing competitive pressures in the TechBio space Despite its innovative RecursionOS platform and partnerships with Bayer and Roche, RXRX is underperforming the industry, sector, and S&P 500. Competitive pressure from $RLAY and $SDGR adds to the challenge. Discover the full story here 👉 https://www.zacks.com/commentary/2560564/can-rxrxs-ai-based-approach-revolutionize-the-drug-discovery-process?cid=sm-stocktwits-2-2560564-body-656&ADID=SYND_STOCKTWITS_TWEET_2_2560564_BODY_656
0 · Reply
TheDrunkTrader69
TheDrunkTrader69 Jul. 2 at 3:02 PM
$RLAY She waking up? I knew eventual she would long term holding know what you have. Very nice
0 · Reply
BBQQ
BBQQ Jun. 30 at 10:44 PM
$RLAY sleeper Google took a position
0 · Reply
BBQQ
BBQQ Jun. 30 at 6:58 PM
$RLAY more shorts than shares. I don’t get this set up. $700M cash; no debt, big names own a massive chunk and 22m shares are short? Is that right?
0 · Reply
Breck100
Breck100 Jun. 26 at 7:45 PM
$RLAY From 6/18/25.
0 · Reply
BioTechHealthX
BioTechHealthX Jun. 20 at 2:57 AM
$RLAY With Phase 3 trials for its PI3Kα inhibitor underway, Relay Therapeutics is entering a critical breakout phase. Learn about it more here! https://biotechhealthx.com/biotech-news/relay-therapeutics-rlay-just-got-fda-backing-heres-why-rlay-stock-could-explode/
0 · Reply
Breck100
Breck100 Jun. 18 at 5:07 PM
0 · Reply
TheDrunkTrader69
TheDrunkTrader69 Jun. 12 at 7:32 PM
$RLAY or not ? 😞
0 · Reply
TheDrunkTrader69
TheDrunkTrader69 Jun. 10 at 5:03 PM
$RLAY Is it just me or does this look like a set up to launch this bad boy to 10. Paying attention to this thing.
0 · Reply
TheDrunkTrader69
TheDrunkTrader69 Jun. 10 at 12:26 AM
$RLAY Not bad for a Monday just saying 😉
0 · Reply
TalkMarkets
TalkMarkets Jun. 9 at 10:32 PM
The MunAIMarket AI-Focused Drug Discovery Stock Portfolio Has Flipped: Down 17% In May; Up 16% Last Week $SDGR $ABCL $RLAY $ABSI $RXRX https://talkmarkets.com/content/stocks--equities/the-munaimarket-ai-focused-drug-discovery-stock-portfolio-has-flipped-down-17-in-may-up-16-last-week?post=502008
0 · Reply
TheDrunkTrader69
TheDrunkTrader69 Jun. 6 at 4:08 PM
$RLAY They are moving to new building and will save 16 million on top of great progress , i see some good movement soon. Very Bullish
0 · Reply
Eroc
Eroc Jun. 6 at 3:47 PM
$RLAY great move today! This one is getting ready to go! Should be an easy 20-30% from these levels!
0 · Reply